Amgen, Plexium Collaborate To Identify Novel Targeted Protein Degradation Therapies
THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) and Plexium Inc. have entered into multi-year, drug discovery collaboration to identify novel targeted protein degradation therapies.The collaboration combines
Source: finanznachrichten.de